“What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

Slides:



Advertisements
Similar presentations
Health and the Web: UK Experience Professor Sir Michael Rawlins Chairman, National Institute for Health and Clinical Excellence And Professor of Clinical.
Advertisements

Booking & Choice Colin Innes Executive Lead Choose and Book.
NIGB NATIONAL INFORMATION GOVERNANCE BOARD Harry Cayton, Chair, National Information Governance Board.
Embedding Shared Decision Making – Lot 2 work programme.
Liberating the NHS HealthWatch DH GATEWAY REF
Definitions Patient Experience Patient experience at NUH results from a range of activities that all impact upon patient care, access, safety and outcomes.
Experiences of Patient and Public involvement in the Research Process Roma Maguire Senior Research Fellow Cancer Care Research Team School of Nursing and.
NICE Guidance and Quality Standard on Patient Experience
How do we achieve cost effective cancer treatments in the UK? Professor Peter Littlejohns Department of Public Health and Primary Care.
Barry G Holland – Consulting Psychologist
The Draft SEN Code of Practice November What the Code is Nine chapters Statutory guidance on duties, policies and procedures relating to Part 3.
Patient, carer and public involvement at NICE Lizzie Amis Patient and Public Involvement Programme (PPIP) National Institute for Health and Clinical Excellence.
A safe space for engagement? Stories from the NICE front line Andrew Dillon Chief Executive National Institute for Health and Clinical Excellence.
CQC registration for providers of Primary Dental Services Medicines Management Caroline Crouch NHS Dorset.
Integrated Personal Commissioning The NHS getting serious about personalisation 30 th October 2014.
Workshop 501 and 505 Review barriers to communication
Working with NICE guidance - preventing unintentional injuries in young people in the Bradford District 18 February 2011 Ralph Saunders Head of Public.
The Challenges for Medicines Optimisation
NICE in a changing world North East Leading Improvement for Health and Well- being programme Professor Mike Kelly Director, Centre for Public Health Excellence.
NICE in a changing world National Leading Improvement for Health and Well-being programme 12 May 2011 Gillian Mathews Implementation consultant.
Promoting Excellence in Family Medicine Enabling Patients to Access Electronic Health Records Guidance for Health Professionals.
Standards Debate at the Centre for Better Managed Health Care, Cass Business School, City University London, 26 th October Professor Mike Kelly Director.
Introducing NICE... Gateshead Council Gillian Mathews Implementation consultant - north.
Introduction to Standard 2: Partnering with consumers Advice Centre Network Meeting Nicola Dunbar October 2012.
Co-designing a Patient & Public Involvement work plan t: w:
Towards a Multi-Agency Knowledge Broker Network
A summary of feedback from service users and carers: Adult Social Care – what does good look like?
National Programme for Mental Health. WHAT IS CLINICAL GOVERNANCE? Clinical governance is a framework through which healthcare teams are accountable.
HEALTH SCRUTINY IN MIDDLESBROUGH Health Scrutiny Panel – 30 June 2015 Elise Pout – Scrutiny Support Officer – Tel
Partners in improving local health NHS Confidential / Protect / Unclassified - Slide 1 Medicines Optimisation So – are we there yet? Janette Stephenson.
A Sustainable Wales Better Choices for a Better Future Sustainable Development White Paper A Sustainable Wales - Better Choices for a Better Future.
NICE: what it is and how it works Professor David Haslam, Chair, NICE 10 th June 2015.
What do patients want from healthcare? Professor David Haslam CBE Chair, NICE Responsible Officers Conference, Brighton.
Live well with Dementia: an achievable goal Age UK Brent Conference Carolyn Denne October 2013.
NICE in my practice Dr Matthew Snowsill Foundation Year Clinical Practice Student Champion
My role Being part of the core MAGIC team for primary care Imbedding shared decision making into the culture of the surgery Writing patient decision aids(PDAs)
Psychological Aspects Of Care To Patients With Chronic Diseases In Different Age.
Sex and drugs and rock ‘n roll
A narrative for person-centred coordinated care Jeremy Taylor 28 June 2013.
November 2014 The Public and Patient Voice in the SW SCN and Senate.
Dr Mary Backhouse Chief Clinical Officer Our ‘Big Questions’
SpringwellSchool Hinkler Road, Thornhill, Southampton, SO19 6DH Supporting pupils at school with medical conditions.
NICE - supporting quality in care homes Deborah O’Callaghan - Implementation Consultant 5 th November 2015.
Person-centred coordinated care: opportunities and challenges for the VCS 1.
Our Vision & Mission 1 OUR MISSION Advancing health and wellbeing for you and your family OUR VISION To become a Foundation Trust with a passion for quality,
Who is involved in making NICE guidance recommendations and what evidence do they look at? Jane Cowl, Senior Public Involvement Adviser Tommy Wilkinson,
Educational solutions for the NHS pharmacy workforce Medicines Optimisation: Helping patients to make the most of medicines Sue Carter Regional Tutor
HEALTH AND CARE STANDARDS APRIL Background Ministerial commitment 2013 – Safe Care Compassionate Care Review “Doing Well Doing Better” Standards.
Sanofi Train the Trainer Programme. Course objectives Understand what advocacy is Understand the roles of decision makers and how to influence them Understand.
Medicines adherence Implementing NICE guidance 2009 NICE clinical guideline 76.
Medicines Optimisation Putting Patients at the Centre of their Care Jabeen Egan Lead Pharmacist.
Service user experience in adult mental health NICE quality standard January 2012.
Learning from patients’ experience Angela Coulter Picker Institute Europe Angela Coulter Picker Institute Europe
Alcohol dependence and harmful alcohol use NICE quality standard August 2011.
The NHS Constitution and patient rights and responsibilities Jessica Britton Associate Director of Quality and Assurance.
Introduction to NICE Professor David Haslam CBE Chair, NICE Student champion Study Day, January 2015.
Introduction to NICE Professor David Haslam CBE Chair, NICE
Making NICE research nicer Involving patients, carers and the public
The NICE Citizens Council and the role of social value judgements
Workforce Planning Framework
Introduction to NICE Professor David Haslam CBE,
Introduction to NICE Professor David Haslam CBE
The patient and carer perspective
NICE: what does dignity mean to us?
Quality Improvement Network Meeting
Diagnosis of disease M2/D2
Dr Rosie Benneyworth Vice-Chair of NICE
Medicines in Adult Social Care Care homes & Care at Home
Why do we request a PIR? The information provided in the PIR helps inspectors to understand how the service meets the five key questions and the plans.
Levels of involvement Consultation Collaboration User control
Presentation transcript:

“What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public Involvement Programme, NICE

“What’s in it for us?” Overview of NICE and developing NICE Guidelines Key messages: NICE Guideline on the safe and effective use of medicines (medicines optimisation) Questions

The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care. The role of NICE To identify good clinical, public health and social care practice using the best available evidence To help resolve uncertainty for the public, patients, service users and professionals To reduce variation in the availability and quality of practice and care.

The Citizens Council: advising on social values The Citizens Council is a panel of 30 members of the public that largely reflect the demographic characteristics of the UK. The Council considers societal and ethical issues relevant to NICE work. For example: -Should NICE take age into account? -Should the NHS pay a premium for treatments for people with rare conditions? -What aspects of benefit, cost and need should NICE take into account when developing social care guidance? Council’s views underpin social value judgements used by NICE committees and other advisory bodies

Core principles of NICE guidance Comprehensive evidence base Expert input Public involvement Independent advisory committees Genuine consultation Regular review Open and transparent process

The importance to users of services and carers “Confidence in the clinical system” “Confidence in staff looking after me” “Understand what treatment to expect” Better patient experience and outcomes Empowers peoples to make choices about their own care A constitutional right to receive treatment and medicines.

The importance for health professionals Guides practice “Brings together what the research tells us in the context of what is already known” “Pragmatic approach to clinical problems seen every day” “Helps me to keep my practice up to date” Health professionals should take NICE guidance into account when deciding what treatments to give people

Developing NICE Guidelines – involving the public Referral Scoping Development Consultation Publication Implementation support Local Healthwatch National organisations Users of services, families and carers

Patient experience in adult NHS services Medicines optimisation Medicines adherence Drug allergy Overarching NICE guidance

Definition of medicines optimisation ‘a person-centred approach to safe and effective medicines use, to ensure people obtain the best possible outcomes from their medicines’

Accurately listing your medicines Sharing information about your medicines What should you expect at a medication review? Using a self-management plan Mistakes with medicines

Identify Prioritise Report Take action Apply and share learning What is a ‘Fair Blame’ culture? Who benefits?

We are KEY in making decisions about our medicines “What’s in it for us?”

Emergency

Shared Decision Making… is a collaborative process that allows patients and their providers to make health care decisions together, taking into account the best scientific evidence available, as well as the patient’s values and preferences Angela Coulter and Alf Collins, The King’s Fund

Shared understanding Information Goals Values Preferences “What’s in it for us?”

Could these questions help you? These questions may help you discuss your condition or the treatments you have been offered with your care team: How often should my medicines be reviewed? Who sees the information about what medicines I'm taking? Will the information about my medicines be kept confidential? What are the benefits of using a self ‑ management plan? Can you tell me about using a patient decision aid? How do I report a side effect or a bad reaction to a medicine? What do I do if I think I no longer need a medicine? What do I do if I think a medicine isn't working? Who do I speak to if I want to stop taking a medicine? What do I do if I think a mistake has been made with my medicines?

We are KEY in making decisions about our medicines “What’s in it for us?”

Questions? Thank you!